Cite
Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes
MLA
Alessandra Beano, et al. “Weekly Cisplatin plus Capecitabine in Metastatic Breast Cancer Patients Heavily Pretreated with Both Anthracycline and Taxanes.” Oncology, vol. 69, no. 5, Feb. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dae855e3db132d5bd29d0442fb58cef8&authtype=sso&custid=ns315887.
APA
Alessandra Beano, Daniele Generali, M.A. Polimeni, Oscar Alabiso, Federico Castiglione, S Bonardi, Mara Ardine, Alfredo Berruti, Oscar Bertetto, Alberto Bottini, Michela Donadio, S Bretti, & Marinella Mistrangelo. (2005). Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes. Oncology, 69(5).
Chicago
Alessandra Beano, Daniele Generali, M.A. Polimeni, Oscar Alabiso, Federico Castiglione, S Bonardi, Mara Ardine, et al. 2005. “Weekly Cisplatin plus Capecitabine in Metastatic Breast Cancer Patients Heavily Pretreated with Both Anthracycline and Taxanes.” Oncology 69 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dae855e3db132d5bd29d0442fb58cef8&authtype=sso&custid=ns315887.